Subscribe to RSS
DOI: 10.1055/s-0033-1341069
Phenylphosphonic Acid as Efficient and Recyclable Catalyst in the Synthesis of α-Aminophosphonates under Solvent-Free Conditions
Publication History
Received: 19 December 2013
Accepted after revision: 03 March 2014
Publication Date:
07 April 2014 (online)
Abstract
Phenylphosphonic acid is an efficient, friendly and reusable heterogeneous catalyst for the synthesis of α-aminophosphonates through a ‘one-pot’ three-component reaction of amines, carbonyl compounds and dialkyl phosphites under solvent-free conditions. This methodology illustrates a very simple procedure, with wide applicability, extending the scope to aliphatic and aromatic amines, aliphatic and aromatic aldehydes and aliphatic ketones. It also enabled the synthesis of α-aminophosphonates in large scale, clean conversion, easy workup and purification. Excellent results were obtained in each case obtaining the desire compounds in moderate to good yields.
-
References and Notes
- 1 Mucha A, Kafarski P, Berlicki Y. J. Med. Chem. 2011; 54: 5955
- 2 Aminophosphinic and Aminophosphonic Acids: Chemistry and Biological Activity. Kukhar VP, Hudson HR. John Wiley & Sons; New York: 2000
- 3 Prasada GS, Rao GN. J. Modern. Med. Chem. 2013; 1: 49
- 4a Orsini F, Sello G, Sisti M. Curr. Med. Chem. 2010; 17: 264
- 4b Moonen K, Laureyn I, Stevens CV. Chem. Rev. 2004; 104: 6177
- 5 Sienczyk M, Oleksyszyn J. Curr. Med. Chem. 2009; 16: 1673
- 6a Ali NA. S, Zakir S, Patel M, Farooqui M. Eur. J. Med. Chem. 2012; 50: 39
- 6b Sampath C, Vani KV, Kotaiah Y, Krishna NH, Raju CN, Rao CV. J. Chem. Pharm. Res. 2012; 4: 1375
- 6c Burchacka E, Walczak MM, Sieńczyk M, Dubin G, Zdźalik M, Potempa J, Oleksyszyn J. Bioorg. Med. Chem. Lett. 2012; 22: 5574
- 6d Krishnaa AB, Reddy MV. N, Reddy GC. S, Krishna BS, Nayak SK, Reddy CS. Int. J. Appl. Biol. Pharm. Technol. 2010; 1: 873
- 7a Bhattacharya AK, Raut DS, Rana KC, Polanki IK, Khan MS, Iram S. Eur. J. Med. Chem. 2013; 66: 146
- 7b Klimczak AA, Kuropatwa A, Lewkowski J, Szemraj J. Med. Chem. Res. 2013; 22: 852
- 7c Kraicheva I, Tsacheva I, Vodenicharova E, Tashev E, Tosheva T, Kril A, Topashka-Ancheva M, Iliev I, Gerasimova T, Troev K. Bioorg. Med. Chem. 2012; 20: 117
- 7d Abdel-Megeed MF, Badr BE, Azaam MM, El-Hiti GA. Bioorg. Med. Chem. 2012; 20: 2252
- 7e Wang Q, Zhu M, Zhu R, Lu L, Yuan C, Xing S, Fu X, Mei Y, Hang Q. Eur. J. Med. Chem. 2012; 49: 354
- 7f Ning L, Wang W, Liang Y, Peng H, Fu L, He H. Eur. J. Med. Chem. 2012; 48: 379
- 7g Reddy CB, Kumar KS, Kumar MA, Reddy MV. N, Krishna BS, Naveen M, Arunasree MK, Reddy CS, Raju CN, Reddy CD. Eur. J. Med. Chem. 2012; 47: 553
- 8a Bhattacharya AK, Rana KC, Pannecouque C, De Clercq E. ChemMedChem 2012; 7: 1601
- 8b Yang J.-Q, Song B.-A, Bhadury PS, Chen Z, Yang S, Cai X.-J, Hu D.-Y. J. Agric. Food Chem. 2010; 58: 2730 ; and references therein
- 9 Sivaraman KK, Paiardini A, Sieńczyk M, Ruggeri C, Oellig CA, Dalton JP, Scammells PJ, Drag M, McGowan S. J. Med. Chem. 2013; 56: 5213 ; and references therein
- 10 Devineni SR, Doddaga S, Donka R, Chamarthi NR. Chin. Chem. Lett. 2013; 24: 759 ; and references therein
- 11 Danila DC, Wang X, Hubble H, Antipin IS, Pinkhassik E. Bioorg. Med. Chem. Lett. 2008; 18: 2320
- 12a Onita N, Şişu I, Penescu M, Purcarea VL, Kurunczi L. Farmacia 2010; 58: 531
- 12b Occhipinti A, Berlicki Ł, Giberti S, Dziędzioła G, Kafarski P, Forlania G. Pest. Manag. Sci. 2010; 66: 51
- 13a Peiser G, López-Gálvez G, Cantwell M, Saltveit ME. J. Am. Soc. Hort. Sci. 1998; 123: 687
- 13b Janas KM, Osiecka R, Zoń J. J. Plant Growth Regul. 1998; 17: 169
- 13c Maier L, Spoerri H. Phosphorus Sulfur Silicon Relat. Elem. 1991; 61: 69
- 14a Malmgren M, Granander J, Amedjkouh M. Tetrahedron: Asymmetry 2008; 19: 1934
- 14b Tao Q, Tang G, Lin K, Zhao Y.-F. Chirality 2008; 20: 833
- 14c Dinér P, Amedjkouh M. Org. Biomol. Chem. 2006; 4: 2091
- 15a Mucha A, Kafarski P, Berlicki L. J. Med. Chem. 2011; 54: 5955
- 15b Naydenova ED, Todorov PT, Troev KD. Amino Acids 2010; 38: 23
- 15c Lejczak B, Kafarski P. Top. Heterocycl. Chem. 2009; 20: 31
- 16a Ordóñez M, Sayago FJ, Cativiela C. Tetrahedron 2012; 68: 6369
- 16b Ordóñez M, Viveros-Ceballos JL, Cativiela C, Arizpe A. Curr. Org. Synth. 2012; 9: 310
- 16c Bhadury PS, Li H. Synlett 2012; 23: 1108
- 16d Kudzin ZH, Kudzin MH, Drabowicz J, Stevens CV. Curr. Org. Chem. 2011; 15: 2015
- 16e Albrecht Ł, Albrecht A, Krawczyk H, Jørgensen KA. Chem. Eur. J. 2010; 16: 28
- 16f Ordóñez M, Rojas-Cabrera H, Cativiela C. Tetrahedron 2009; 65: 17
- 17 Kabachnik MI, Medved T. Dokl. Acad. Nauk. SSSR 1952; 83: 689
- 18a Dar BA, Chakraborty A, Sharma PR, Shrivastava V, Bhowmik A, Vyas D, Bhatti P, Sharma M, Singh B. J. Ind. Eng. Chem. 2013; 19: 732
- 18b Hamadi H, Kooti M, Afshari M, Ghiasifar Z, Adibpour N. J. Mol. Catal. A: Chem. 2013; 373: 25
- 18c Sharghi H, Ebrahimpourmoghaddam S, Doroodmand MM. Tetrahedron 2013; 69: 4708
- 18d Zhang Y, Zhu C. Catal. Commun. 2012; 28: 134
- 18e Disale ST, Kale SR, Kahandal SS, Srinivasan TG, Jayaram RV. Tetrahedron Lett. 2012; 53: 2277
- 18f Sundar CS, Srinivasulu D, Nayak SK, Reddy CS. Phosphorus Sulfur Silicon Relat. Elem. 2012; 187: 523
- 18g Sheykhan M, Mohammadnejad H, Akbari J, Heydari A. Tetrahedron Lett. 2012; 53: 2959
- 19 Tibhe GD, Bedolla-Medrano M, Cativiela C, Ordóñez M. Synlett 2012; 23: 1931
- 20 Ragaini F, Cognolato C, Gasperini M, Cenini S. Angew. Chem. Int. Ed. 2003; 42: 2886
- 21 Pan SC, Benjamin ListB. Angew. Chem. Int. Ed. 2008; 47: 3622
- 22 Sagar AD, Reddy SM, Pulle JS, Yadav MV. J. Chem. Pharm. Res. 2011; 3: 649
- 23 Augustine JK, Bombrun A, Alagarsamy P, Jothi A. Tetrahedron Lett. 2012; 53: 6280
- 24 In a typical experiment, to a mixture of aldehyde or ketone (2.0 mmol) and benzylamine (2.0 mmol) was added the phenylphosphonic acid (5; 10 mol%). The reaction mixture was stirred at r.t. for 20 min. After this time, dimethyl phosphite (2.1 mmol) was added and the reaction mixture was stirred at 50 °C for the specific period of time (see Tables 1–3), and the progress of the reaction was monitored by TLC. The crude was directly subjected to silica gel flash chromatography eluting with EtOAc, obtaining the pure α-aminophosphonates. 1H NMR, 13C NMR, 31P NMR, and HRMS data for some newly obtained α-aminophosphonates are as follows. Compound 6g: yellow liquid. 1H NMR (400 MHz, CDCl3): δ = 3.48 [d, J = 10.5 Hz, 3 H, (MeO)2P], 3.52 (AB system, J = 13.3 Hz, 1 H, Bn), 3.78 (AB system, J = 13.3 Hz, 1 H, Bn), 3.79 [d, J = 10.6 Hz, 3 H, (MeO)2P], 3.89 (d, J = 20.1 Hz, 1 H, CHP), 6.63 (ddd, J = 8.0, 2.0, 2.0 Hz, 1 H, HAr), 6.77 (d, J = 8.0 Hz, 1 H, HAr), 7.11 (dd, J = 2.0, 2.0 Hz, 1 H, HAr), 7.20–7.31 (m, 5 H, HAr). 13C NMR (100 MHz, CDCl3): δ = 50.8 (d, J = 17.6 Hz, Bn), 53.8 [d, J = 7.1 Hz, (MeO)2P], 54.1 [d, J = 7.6 Hz, (MeO)2P], 58.2 (d, J = 157.8 Hz, CHP), 114.7 (d, J = 5.0 Hz), 115.1, 121.0 (d, J = 8.1 Hz), 126.0, 127.2, 128.4 (2 × C), 139.0, 145.0 (2 × C). 31P NMR (161.9 MHz, CDCl3): δ = 26.62. HRMS (FAB+): m/z [M + H]+ calcd for C16H21NO5P: 338.1157; found: 338.1159. Compound 6k: white solid; mp 94–96 °C. 1H NMR (400 MHz, CDCl3): δ = 2.44 (br s, 1 H, NH), 3.58 (AB system, J = 13.3 Hz, 1 H, Bn), 3.58 [d, J = 10.5 Hz, 3 H, (MeO)2P], 3.75 [d, J HP = 10.6 Hz, 3 H, (MeO)2P], 3.84 (AB system, J = 13.3 Hz, 1 H, Bn), 4.10 (d, J = 20.2 Hz, 1 H, CHP), 7.22–7.36 (m, 6 H, HAr), 7.40–7.52 (m, 4 H, HAr), 7.59–7.64 (m, 4 H, HAr). 13C NMR (100 MHz, CDCl3): δ = 51.3 (d, J = 17.4 Hz, Bn), 53.6 [d, J = 6.6 Hz, (MeO)2P], 53.9 [d, J = 6.6 Hz, (MeO)2P], 59.1 (d, J = 154.3 Hz, CHP), 127.1, 127.3, 127.4, 127.5, 128.5 (d, J = 6.7 Hz), 128.9, 129.1 (d, J = 5.5 Hz), 134.6, 139.3, 140.7, 140.9, 141.0. 31P NMR (161.9 MHz, CDCl3): δ = 23.05. HRMS (FAB+): m/z [M + H]+ calcd for C22H25NO3P: 382.1572; found: 382.1588. Compound 6l: colorless liquid. 1H NMR (400 MHz, CDCl3): δ = 2.17 (br s, 1 H, NH), 3.52 (AB system, J = 13.3 Hz, 1 H, Bn), 3.58 [d, J = 10.6 Hz, 3 H, (MeO)2P], 3.74 [d, J = 10.6 Hz, 3 H, (MeO)2P], 3.80 (AB system, J = 13.3 Hz, 1 H, Bn), 3.93 (s, 3 H, MeO), 4.13 (d, J = 20.7 Hz, 1 H, CHP), 7.21–7.36 (m, 5 H, HAr), 7.52 (AA′BB′ system, J = 8.3, 2.2 Hz, 2 H, HAr), 8.06 (AA′BB′ system, J = 8.3 Hz, 2 H, HAr). 13C NMR (100 MHz, CDCl3): δ = 51.5 (d, J = 17.3 Hz, Bn), 52.3 (MeO2C), 53.7 [d, J = 6.9 Hz, (MeO)2P], 54.0 [d, J = 6.9 Hz, (MeO)2P], 59.4 (d, J = 152.8 Hz, CHP), 127.5, 128.5, 128.7, 128.8 (d, J = 5.9 Hz), 130.0, 130.1, 138.9, 141.1, 166.9. 31P NMR (161.9 MHz, CDCl3): δ = 22.15. HRMS (FAB+): m/z [M + H]+ calcd for C18H23NO5P: 364.1314; found: 364.1322. Compound 6n: white solid; mp 59–62 °C. 1H NMR (400 MHz, CDCl3): δ = 2.35 (br s, 1 H, NH), 3.52 (AB system, J = 13.2 Hz, 1 H, CH2Ph), 3.61 [d, J = 10.6 Hz, 3 H, (MeO)2P], 3.74 [d, J = 10.6 Hz, 3 H, (MeO)2P], 3.79 (AB system, J = 13.2 Hz, 1 H, CH2Ph), 4.12 (d, J = 20.6 Hz, 1 H, CHP), 7.21–7.35 (m, 5 H, HAr), 7.55 (AA′BB′ system, J = 8.1, 1.4 Hz, 2 H, HAr), 7.64 (AA′BB′ system, J = 8.1 Hz, 2 H, HAr). 13C NMR (100 MHz, CDCl3): δ = 51.5 (d, J = 17.1 Hz, CH2Ph), 53.7 [d, J = 6.9 Hz, (MeO)2P], 54.0 [d, J = 7.0 Hz, (MeO)2P], 59.3 (d, J = 153.0 Hz, CHP), 124.3 (q, J = 275.0, CF3), 125.7 (dq, J = 3.6, 3.6 Hz), 127.6, 128.5, 128.7, 129.1 (d, J = 5.9 Hz), 130.4 (dq, J = 32.2, 2.9 Hz), 138.9, 140.1 (d, J = 3.5 Hz). 31P NMR (161.9 MHz, CDCl3): δ = 24.78 (q, J = 2.5 Hz). HRMS (FAB+): m/z [M + H]+ calcd for C17H20F3NO3P: 374.1133; found: 374.1035. Compound 6p: yellow liquid. 1H NMR (400 MHz, CDCl3): δ = 2.56 (br s, 1 H, NH), 3.43 [d, J = 10.4 Hz, 3 H, (MeO)2P], 3.60 (AB system, J = 13.4 Hz, 1 H, CH2Ph), 3.74 [d, J = 10.5 Hz, 3 H, (MeO)2P], 3.82 (AB system, J = 13.4 Hz, 1 H, CH2Ph), 4.09 (d, J = 20.2 Hz, 1 H, CHP), 6.10–6.17 (m, 2 H, HAr), 6.78 (ddd, J = 4.3, 2.6, 1.8 Hz, 1 H, HAr), 7.18–7.35 (m, 5 H, HAr), 9.71 (br s, 1 H, NH-pyrrole). 13C NMR (100 MHz, CDCl3): δ = 51.2 (d, J = 16.9 Hz, CH2Ph), 52.5 (d, J = 160.4 Hz, CHP), 53.5 [d, J = 6.9 Hz, (MeO)2P], 53.9 [d, J = 7.0 Hz, (MeO)2P], 108.1, 109.5 (d, J = 9.4 Hz), 119.0, 124.8 (d, J = 5.4 Hz), 127.2, 128.4, 128.5, 139.5. 31P NMR (161.9 MHz, CDCl3): δ = 22.70. HRMS (FAB+): m/z [M + H]+ calcd for C14H20N2O3P: 295.1212; found: 295.1224. Compound 6q: yellow liquid. 1H NMR (200 MHz, CDCl3): δ = 1.94 (br s, 1 H, NH), 3.60 (AB system, J = 13.3 Hz, 1 H, Bn), 3.64 [d, J = 10.6 Hz, 3 H, (MeO)2P], 3.81 [d, J = 10.6 Hz, 3 H, (MeO)2P], 3.87 (AB system, J = 13.3 Hz, 1 H, Bn), 4.12 (d, J = 22.2 Hz, 1 H, CHP), 6.36–6.42 (m, 2 H, HAr), 7.22–7.35 (m, 5 H, HAr), 7.46 (ddd, J = 2.5, 1.8, 0.8 Hz, 1 H, HAr). 13C NMR (100 MHz, CDCl3): δ = 51.3 (d, J = 16.4 Hz, CH2Ph), 52.7 (d, J = 162.5 Hz, CHP), 53.4 [d, J = 6.9 Hz, (MeO)2P], 53.9 [d, J = 6.8 Hz, (MeO)2P], 109.5 (d, J = 7.5 Hz), 110.6, 127.2, 128.4 (2 × C), 138.8, 142.7 (2 × C). 31P NMR (81 MHz, CDCl3): δ = 23.36. HRMS (FAB+): m/z [M + H]+ calcd for C14H19NO4P: 296.1052; found: 296.1039. Compound 6r: colorless oil. 1H NMR (400 MHz, CDCl3): δ = 0.88 (t, J = 7.3 Hz, 3 H, Me), 1.31–1.43 (m, 1 H, CH2), 1.49–1.64 (m, 3 H, NH, CH2), 1.68–1.81 (m, 1 H, CH2), 2.91 (ddd, J = 12.2, 8.5, 4.6 Hz, 1 H, CHP), 3.77 [d, J = 9.9 Hz, 3 H, (MeO)2P], 3.80 [d, J = 9.9 Hz, 3 H, (MeO)2P], 3.87 (AB system, J = 13.1, 1.8 Hz, 1 H, Bn), 3.96 (AB system, J = 13.1 Hz, 1 H, Bn), 7.20–7.37 (m, 5 H, HAr). 13C NMR (100 MHz, CDCl3): δ = 14.0 (Me), 19.4 (d, J = 10.9 Hz, CH2), 32.1 (CH2), 52.3 (d, J = 5.0 Hz, CH2Ph), 52.8 [d, J = 7.6 Hz, (MeO)2P], 53.0 [d, J = 6.4 Hz, (MeO)2P], 53.7 (d, J = 149.4 Hz, CHP), 127.2, 128.5 (2 × C), 140.1. 31P NMR (161.9 MHz, CDCl3): δ = 28.35. HRMS (FAB+): m/z [M + H]+ calcd for C13H23NO3P: 272.1416; found: 272.1415.
- 25a Failes TW, Battle AR, Chen C, Cullinane C, Woods R, Elliott R, Deacon GB, Hambley TW. J. Inorg. Biochem. 2012; 115: 220
- 25b Quin LD, Dysart MR. J. Org. Chem. 1962; 27: 1012
- 25c Ohta K. Bull. Chem. Soc. Jpn. 1992; 65: 2543
- 25d Nagarajan K, Shelly KP, Perkins RR, Stewart R. Can. J. Chem. 1987; 65: 1729
- 26a Heydari A, Karimian A, Ipaktschi J. Tetrahedron Lett. 1998; 39: 6729
- 26b Saidi MR, Azizi N. Synlett 2002; 1347
- 27a Tibhe GD, Labastida-Galván V, Ordóñez M. Rapid Commun. Mass Spectrom. 2011; 25: 951
- 27b Tibhe GD, Lagunas-Rivera S, Vargas-Díaz E, García-Barradas O, Ordoñez M. Eur. J. Org. Chem. 2010; 6573
- 28 Akiyama T, Morita H, Itoh J, Fuchibe K. Org. Lett. 2005; 7: 2583
For representative publications, see:
For representative publications, see:
For representative publications, see: